FDA Inspection 859037 — Lin, James P MD Inc. D.B.A. Reproductive Fertility Center

Lin, James P MD Inc. D.B.A. Reproductive Fertility Center — FEI 3005405736

The FDA completed an inspection of Lin, James P MD Inc. D.B.A. Reproductive Fertility Center on Dec 24, 2013 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 24, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223221 CFR 1271.50(b)(2)Donor testing not negative for CD agents
1223921 CFR 1271.55(b)(2)Listing and interpretation of CD tests performed
1224321 CFR 1271.55(d)(1)Documentation maintained (general)
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1228721 CFR 1271.80(c)Kits not FDA approved, specifically labeled
1230121 CFR 1271.150(c)(1)(iii)Ensurane of compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.